123 related articles for article (PubMed ID: 37518954)
1. Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.
Downing A; Fenton H; Nickerson C; Loadman PM; Williams EA; Rees CJ; Brown LC; Morris EJA; Hull MA
Aliment Pharmacol Ther; 2023 Sep; 58(6):562-572. PubMed ID: 37518954
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
[TBL] [Abstract][Full Text] [Related]
5. The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E
Sun G; Fuller H; Fenton H; Race AD; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Int J Cancer; 2024 Mar; 154(5):873-885. PubMed ID: 37855394
[TBL] [Abstract][Full Text] [Related]
6. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
10. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
11. Nonneoplastic polypectomy during screening colonoscopy: the impact on polyp detection rate, adenoma detection rate, and overall cost.
Atia MA; Patel NC; Ratuapli SK; Boroff ES; Crowell MD; Gurudu SR; Faigel DO; Leighton JA; Ramirez FC
Gastrointest Endosc; 2015 Aug; 82(2):370-375.e1. PubMed ID: 25843614
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
13. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study.
van Toledo DEFWM; IJspeert JEG; Bossuyt PMM; Bleijenberg AGC; van Leerdam ME; van der Vlugt M; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):747-754. PubMed ID: 35550250
[TBL] [Abstract][Full Text] [Related]
14. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
15. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex.
Vojtechova G; Ngo O; Grega T; Kmochova K; Voska M; Buckova B; Majek O; Zavoral M; Suchanek S
Eur J Cancer Prev; 2020 Jul; 29(4):294-302. PubMed ID: 32543806
[TBL] [Abstract][Full Text] [Related]
16. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials.
Juul FE; Garborg K; Nesbakken E; Løberg M; Wieszczy P; Cubiella J; Kalager M; Kaminski MF; Erichsen R; Adami HO; Ferlitsch M; Furholm SKB; Zauber AG; Quintero E; Bugajski M; Holme Ø; Dekker E; Jover R; Bretthauer M
Gut; 2023 May; 72(5):951-957. PubMed ID: 36307178
[TBL] [Abstract][Full Text] [Related]
17. Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Lee TJ; Hull MA; Rajasekhar PT; Clifford GM; Ritchie M; James P; McNally RJ; Rutter MD; Rees CJ
Digestion; 2012; 85(4):278-81. PubMed ID: 22538301
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a real-time computer-aided polyp detection system during screening colonoscopy: AI-DETECT study.
Ahmad A; Wilson A; Haycock A; Humphries A; Monahan K; Suzuki N; Thomas-Gibson S; Vance M; Bassett P; Thiruvilangam K; Dhillon A; Saunders BP
Endoscopy; 2023 Apr; 55(4):313-319. PubMed ID: 36509103
[TBL] [Abstract][Full Text] [Related]
19. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study.
Leung K; Pinsky P; Laiyemo AO; Lanza E; Schatzkin A; Schoen RE
Gastrointest Endosc; 2010 Jan; 71(1):111-7. PubMed ID: 19647250
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
